Clinical Trial

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D

Study acronym: EVOLUTIONT1D
Recruiting
View on ClinicalTrials.gov →
Summary
Feasibility study to evaluate the safety and feasibility of Omnipod automated insulin delivery algorithms in individuals with type 1 diabetes. This study will enroll up to 80 participants to have a minimum of 48 participants to initiate the use of Omnipod. The study will include hotel and outpatient evaluation periods.
Protocol Amendment History 6 changes
critical Recruitment opened 2026-07-19
critical Primary endpoint(s) modified 2026-07-19
notable Enrollment increased: 40 -> 80 participants 2026-07-19
minor Trial arms changed: 1 -> 2 2026-07-19
notable Primary completion pushed: 2026-08-30 -> 2026-12-31 2026-07-19
minor Completion pushed: 2026-08-30 -> 2027-02-01 2026-07-19
Trial Details
NCT Number NCT07593625
Lead Sponsor Insulet Corporation
Conditions Type 1 Diabetes, Type 1 Diabetes Mellitus, Diabetes (DM)
Enrollment 80 participants
Start Date 2026-05-25
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-20